tirzepatide and semaglutide side effects caused roughly half as many patients to stop treatment because of gastrointestinal as semaglutide. In the first major head-to-head obesity trial, GI side effects caused treatment discontinuation in: Tirzepatide Semaglutide vs Tirzepatide for Weight

clinical trials that had been conducted were too small from which to generalize

SSRIs (sertraline, escitalopram, fluoxetine), SNRIs (venlafaxine, duloxetine), bupropion, mirtazapine: No clinically significant interactions with semaglutide

Neuroinflammation is a critical factor contributing to cognitive dysfunction and neurodegenerative diseases

These were small, short studies, and there is no published human pharmacokinetic data for the routes most patients are interested in

How MIC and B12 Injections Fit Into a Supervised Program Lipotropic injections are not a standalone solution for significant, durable weight loss

In contrast, fatty liver disease is a metabolic condition where corticosteroids provide no therapeutic benefit and actually worsen the underlying fat accumulation, insulin resistance, and cardiovascular risk factors